MENU
  • Home
  • Vision
  • Neoantigens
  • Company
  • News
  • Contact
  • Japanese
ノバセラム株式会社
  • Home
  • Vision
  • Neoantigens
  • Company
  • News
  • Contact
  • Japanese
ノバセラム株式会社
  • Home
  • Vision
  • Neoantigens
  • Company
  • News
  • Contact
  • Japanese
  1. Home
  2. News

News

    News
    news_bg
    mainvisual-slider-img002
  • 2025-11-25
    notice

    Many Neoantigen Candidates Identified by Isolating Circulating Tumor Cells (CTCs) from Blood and Performing Genomic Analysis—Paper Published

  • 2025-10-01
    notice

    Notice to Participants Who Took Part in the Feasibility Study of Neoantigen DC Therapy

  • 2025-08-25
    notice

    Circulating Tumor Cell–Derived Neoantigen Peptide Study Group Website Now Live

  • 2025-08-22
    notice

    Notice of Becoming a Wholly Owned Subsidiary

  • 2024-01-24
    patents

    Domestic patent granted

  • 2023-11-27
    notice

    A project to promote “custom-made” medical care using genomic information has been launched

  • 2022-06-30
    contract

    Joint research agreement concluded with the National Cancer Center Research Institute

  • 2022-06-30
    notice

    PCT international application filed

  • 2022-01-15
    contract

    Joint research agreement signed with Musashino University

  • 2021-12-10
    contract

    Joint research agreement concluded with the National Institute for Materials Science

12
  • Home
  • Contact Us
  • Company

© Novacellum Inc.